Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Aircraft runway incursions rise in Canada, but one key metric levels off

April 6, 2026

‘They’re intense’: Transport Canada seeks feedback on bright vehicle headlights

April 6, 2026

HII Teams with GrayMatter Robotics to Integrate Physical AI into Manned and Unmanned Shipbuilding

April 6, 2026

APO Productivity Outlook 2026 Highlights Energy Efficiency as a Driver of Productivity Growth

April 6, 2026

Port Alberni harbour residents say noise pollution is affecting their way of life

April 6, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Topical Drugs Market Trends Analysis Report 2025-2030, with Profiles of Bayer, Cipla, GSK, Novartis, Bausch Health Companies, Hisamitsu Pharmaceuticals, Merck, Glenmark Pharmaceuticals & MedPharm
Press Release

Topical Drugs Market Trends Analysis Report 2025-2030, with Profiles of Bayer, Cipla, GSK, Novartis, Bausch Health Companies, Hisamitsu Pharmaceuticals, Merck, Glenmark Pharmaceuticals & MedPharm

By News RoomJanuary 17, 20255 Mins Read
Topical Drugs Market Trends Analysis Report 2025-2030, with Profiles of Bayer, Cipla, GSK, Novartis, Bausch Health Companies, Hisamitsu Pharmaceuticals, Merck, Glenmark Pharmaceuticals & MedPharm
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) — The “Topical Drugs Market Size, Share & Trends Analysis Report By Route Of Administration, By Type, By End Use, By Region, And Segment Forecasts, 2025 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global topical drugs market size is expected to reach USD 269.3 billion by 2030. The industry is expected to grow at a CAGR of 6% from 2025 to 2030.

The key factors contributing to the industry growth include the increased prevalence of skin disorders coupled with strategic collaborations between key players. The increasing prevalence of skin infections, such as psoriasis, atopic dermatitis, and eczema, coupled with the rising demand for eye and ear therapies is expected to drive the demand for transdermal or dermal medicines during the forecast period. For instance, in October 2021, AbbVie Inc. received FDA approval for Vuity, a pilocarpine HCl ophthalmic solution for treating presbyopia.

In addition, according to the NCBI, the prevalence of psoriasis is nearly 1.92% and 1.5% among European and North American populations. The launch of topical medicines to treat skin diseases is also anticipated to propel the demand for dermal drugs. For instance, in September 2020, Bausch Health, Canada launched a novel antipsoriatic agent, Duobrii lotion for psoriasis patients.Advancements in technology and increased acquisitions and mergers activities among key players, such as Alcon, Inc. and Novartis AG, are anticipated to boost the industry’s growth. For instance, in June 2022, Novartis AG acquired Kedalion Therapeutics, thereby acquiring AcuStream technology to facilitate accurate dermal delivery of ophthalmic medicines.

Moreover, in May 2022, Alcon Inc. acquired Eysuvis (loteprednol etabonate suspension) for topical ophthalmic use from Kala Pharmaceuticals, Inc., thereby adding to its existing portfolio of dry eye drugs.A high incidence of burn injuries is expected to render high utilization of topical medicines in treating burn injuries. For instance, according to the WHO, an estimated 11 million burn injuries occur annually worldwide, out of which about 180,000 cases are fatal. Various topical agents are used in treating burn injuries including silver sulfadiazine cream, bismuth-impregnated petroleum gauze, cerium nitrate, mafenide acetate, and nanocrystalline silver among others.

Topical Drugs Market Report Highlights

  • Dermal drug delivery dominated the market and accounted for a share of 54.1% in 2024, fueled by its capacity to offer targeted treatment, user-friendly application, and improved patient compliance.
  • Semi-solid formulations led the market with a revenue share of 61.9% in 2024 due to their versatility, ease of use, and effectiveness in delivering active ingredients directly to the skin.
  • Hospitals & clinics held the largest revenue share of 38.9% in 2024, driven by the growing prevalence of skin disorders and chronic diseases necessitating professional intervention.
  • North America topical drugs market dominated the global market in 2024, driven by a high prevalence of skin disorders, advanced healthcare infrastructure, and robust investments in research and development.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Key Attributes:

Report Attribute Details
No. of Pages 100
Forecast Period 2024 – 2030
Estimated Market Value (USD) in 2024 $190.5 billion
Forecasted Market Value (USD) by 2030 $269.3 billion
Compound Annual Growth Rate 6.0%
Regions Covered Global

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Topical Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis

Chapter 4. Topical Drugs Market: Route of Administration Business Analysis
4.1. Route of Administration Market Share, 2024 & 2030
4.2. Route of Administration Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
4.4. Dermal Drug Delivery
4.5. Ophthalmic Drug Delivery
4.6. Rectal Drug Delivery
4.7. Vaginal Drug Delivery
4.8. Nasal Drug Delivery

Chapter 5. Topical Drugs Market: Type Business Analysis
5.1. Type Market Share, 2024 & 2030
5.2. Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Semi-solid Formulations
5.4.2. Creams
5.4.3. Ointments
5.4.4. Lotions
5.4.5. Gel
5.4.6. Pastes
5.5. Liquid Formulations
5.5.2. Suspensions
5.5.3. Solutions
5.6. Solid Formulations
5.6.2. Powders
5.6.3. Suppositories
5.7. Transdermal Products
5.7.2. Transdermal Patches
5.7.3. Transdermal Semi-Solids

Chapter 6. Topical Drugs Market: End Use Business Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Home Care Settings
6.5. Hospitals & Clinics
6.6. Burn Centers
6.7. Other Facilities

Chapter 7. Topical Drugs Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.4. North America
7.5. Europe
7.6. Asia Pacific
7.7. Latin America
7.8. MEA

Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing

  • Bayer
  • Cipla
  • GSK
  • Johnson & Johnson Services
  • Novartis
  • Bausch Health Companies
  • Hisamitsu Pharmaceuticals Co.
  • Merck
  • Glenmark Pharmaceuticals
  • MedPharm

For more information about this report visit https://www.researchandmarkets.com/r/xvf8kw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

HII Teams with GrayMatter Robotics to Integrate Physical AI into Manned and Unmanned Shipbuilding

APO Productivity Outlook 2026 Highlights Energy Efficiency as a Driver of Productivity Growth

Michigan Rally House Stores to Reopen with a Wolverines Win

Crypto News: AlphaPepe AI DEX Demo Drops Soon While Bitcoin Price Prediction Forecasts $125K

Bring Your Own Cup Day Returns to 7-Eleven Canada

John Pachnos Introduces Himself with a Fully Formed Vision on “John Pachnos,” Arriving May 15 On Avgonyma Music

Dycom Industries, Inc. Appoints Regina Salazar as Chief Information and Digital Officer

MISTR Founder Tristan Schukraft Joins the Producing Team of Titanique

SynGas OBD Fuel Saver Review 2026: Does This Smart Device Actually Cut Your Fuel Costs?

Editors Picks

‘They’re intense’: Transport Canada seeks feedback on bright vehicle headlights

April 6, 2026

HII Teams with GrayMatter Robotics to Integrate Physical AI into Manned and Unmanned Shipbuilding

April 6, 2026

APO Productivity Outlook 2026 Highlights Energy Efficiency as a Driver of Productivity Growth

April 6, 2026

Port Alberni harbour residents say noise pollution is affecting their way of life

April 6, 2026

Latest News

Lady Gaga cancels final Montreal show hours before performance

April 6, 2026

BC Ferries employees working 7 days a week to maintain vessels: union says

April 6, 2026

Michigan Rally House Stores to Reopen with a Wolverines Win

April 6, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version